BeiGene, Ltd. (BGNE)
FDA Applications
Note: This list only includes applications that have been responded to by the FDA.
Application | Product Name | Active Ingredient | Form | Strength | Status | ||
---|---|---|---|---|---|---|---|
BLA761232 - BEIGENE | |||||||
TEVIMBRA | TISLELIZUMAB-JSGR | INJECTION;SOLUTION | 100MG/10ML | Prescription | |||
NDA213217 - BEIGENE | |||||||
BRUKINSA | ZANUBRUTINIB | CAPSULE;ORAL | 80MG | Prescription |